Suppr超能文献

二巯基金属结合剂会影响兔子体内亚砷酸盐的生物转化。

Dimercaptan metal-binding agents influence the biotransformation of arsenite in the rabbit.

作者信息

Maiorino R M, Aposhian H V

出版信息

Toxicol Appl Pharmacol. 1985 Feb;77(2):240-50. doi: 10.1016/0041-008x(85)90323-0.

Abstract

The urinary metabolites of sodium arsenite have been investigated in rabbits given sodium arsenite and water-soluble dimercaptans. Rabbits injected sc with NaAsO2 (1 mg As/kg) were given, im 1 hr later, either saline, 2,3-dimercapto-1-propanesulfonic acid (DMPS), mesodimercaptosuccinic acid (DMSA), or N-(2,3-dimercaptopropyl)phthalamidic acid (DMPA) at 0.2 mmol/kg. Arsenic metabolites in urine collected from treated rabbits were isolated by combined anion-cation-exchange chromatography. Column fractions were acid-digested and analyzed for arsenic by direct hydride-flame atomic absorption spectrophotometry. The relative amounts of inorganic arsenic, methylarsonate, and dimethylarsinate found in 0 to 24 hr urine of rabbits given only sodium arsenite agreed closely with those reported for human subjects given arsenite po. This finding suggests that the rabbit biotransforms arsenite in a manner very similar to that of man. The urinary excretion of total arsenic between 0 and 24 hr was elevated after dimercaptan administration, but urinary excretion of total arsenic between 0 and 48 hr was unaffected. This result indicates that the action of these dimercaptans occurs early after treatment. In addition, the dimercaptans influenced differently the amounts of the arsenic metabolites excreted in the urine between 0 and 24 hr. DMPS, DMSA, or DMPA increased arsenite excretion but decreased dimethylarsinate excretion. DMPS or DMPA treatment increased methylarsonate excretion but DMSA did not. Arsenate excretion increased after DMPS or DMSA treatment but was not affected by DMPA treatment. These results suggest that the dimercaptans, in addition to increasing arsenic excretion, also influence the biotransformation of arsenite to less toxic species. The different effects on the urinary excretion of arsenic metabolites suggest that these dimercaptan metal binding agents have mechanisms of action in addition to simple chelation of inorganic arsenic.

摘要

在给兔注射亚砷酸钠和水溶性二巯基化合物后,对亚砷酸钠的尿代谢产物进行了研究。给兔皮下注射NaAsO₂(1mg砷/千克),1小时后肌肉注射0.2mmol/千克的生理盐水、2,3-二巯基-1-丙磺酸钠(DMPS)、二巯基丁二酸(DMSA)或N-(2,3-二巯基丙基)邻苯二甲酰胺酸(DMPA)。通过阴离子-阳离子交换色谱联用从处理过的兔收集的尿液中分离砷代谢产物。将柱馏分进行酸消解,并通过直接氢化物-火焰原子吸收分光光度法分析砷。仅给予亚砷酸钠的兔在0至24小时尿液中发现的无机砷、甲基胂酸和二甲基胂酸的相对量与口服亚砷酸盐的人类受试者报告的量非常一致。这一发现表明兔对亚砷酸盐的生物转化方式与人类非常相似。给予二巯基化合物后,0至24小时总砷的尿排泄量增加,但0至48小时总砷的尿排泄量未受影响。该结果表明这些二巯基化合物的作用在治疗后早期出现。此外,二巯基化合物对0至24小时尿液中排泄的砷代谢产物的量有不同影响。DMPS、DMSA或DMPA增加了亚砷酸盐排泄,但减少了二甲基胂酸排泄。DMPS或DMPA处理增加了甲基胂酸排泄,但DMSA没有。DMPS或DMSA处理后砷酸盐排泄增加,但不受DMPA处理影响。这些结果表明,二巯基化合物除了增加砷排泄外,还影响亚砷酸盐向毒性较小的物种的生物转化。对砷代谢产物尿排泄的不同影响表明,这些二巯基金属结合剂除了简单螯合无机砷外还有作用机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验